Dublin, Oct. 12, 2017 -- The "Biochips and Microarrays - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to Research and Markets' offering.
This report is an analysis of biochip/microarray markets based on technologies and applications. The report starts with a description of technologies as a basis for estimation of markets. Technologies include array comparative genomic hybridization (CGH), copy number variation (CNV), DNA methylation, ChIP-Chip, RNA splice variants, and microRNA. Separate chapters are devoted to protein biochips/microarrays, microfluidics and nanobiotechnology-based nano-arrays.
Various applications of biochips and microarrays are described throughout the report. Areas of application such as point-of-care, genetic screening, cancer, and diagnosis of infections are included. Separate chapters are devoted to applications in drug discovery and development as well as personalized medicine
The report provides current share of each segment: market size in 2016 and projected value for the years 2021 and 2026. Gene expression has the largest share and is an established market. Share of microarray technologies in other areas will grow with the maximum growth in RNA splice variants followed by epigenetics.
The growth in protein microarrays is somewhat less, partly because it is more mature than the other submarkets and has already shown considerable growth in the past. Impact of next generation sequencing on segments of microarray markets is identified. Customer requirements and unmet needs are described. Markets are also analyzed according to geographical areas.
Brief profiles of companies involved in biochip/microarray technologies are provided. Currently selected 92 companies are included along with listing of 120 collaborations between companies. The text is supplemented by 21 tables, 11 figures and 140 references to literature.
Key Topics Covered:
Executive Summary
1. Introduction
2. Biochip and Microarray Technologies
3. Microfluidics-based Biochips and Microarrays
5. Nanobiotechnology-based Biochips & Microarrays
6. Biochips & Microarrays for Epigenetics
7. Applications of Microarrays in Drug Discovery & Development
8. Biochips for Biomarkers, Molecular Diagnostics & Personalized
9. Markets
10. Companies
11. References
For more information about this report visit https://www.researchandmarkets.com/research/7h2lj5/biochips_and
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology


TSMC Posts Record Q1 2026 Profits Driven by Surging AI Chip Demand
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Chinese Cars in Europe: Consumer Trust Is Shifting Fast
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Meta Is Building an AI Version of Mark Zuckerberg to Interact With Employees
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Jefferies Upgrades Starbucks to Hold as China JV Deal Closes and U.S. Business Shows Signs of Recovery 



